echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Immunology News > JAMA Dermatol: Nomacopan is well tolerated and effective in elderly patients with bullous pemphigoid

    JAMA Dermatol: Nomacopan is well tolerated and effective in elderly patients with bullous pemphigoid

    • Last Update: 2022-08-15
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Bullous pemphigoid is a difficult-to-treat autoimmune bullous skin disease that primarily affects older adults and is associated with increased mortali.


    This multicenter, single-arm, phase 2a non-randomized controlled trial was conducted at university dermatology departments in the Netherlands and Germa.


    RESULTS: A total of 9 patients with bullous pemphigoid (median [range] age, 75 [55-85] years) were included in the trial, 5 of whom were women (56.


    Taken together, the results of this non-randomized controlled trial suggest that Nomacopan is well tolerated in elderly patients with bullous pemphigoid and may have a therapeutic effect in suppressing the exacerbation of this disea.


    Original source:

    Christian D Sadik, et .


    leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.